MedTrace Logo

Effect of Topical Dexmedetomidine on Intraocular Pressure

NCT03690622 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 49

Last updated 2018-10-03

No results posted yet for this study

Summary

Evaluate the short-term safety and efficacy of dexmedetomidine (0.0055%) drops on intraocular pressure (IOP) in healthy eyes.

Conditions

Interventions

DRUG

Dexmedetomidine

Instillation of eyedrops

DRUG

Balanced salt solution

instillation of eyedrop

Sponsors & Collaborators

  • Beirut Eye Specialist Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-12-01
Primary Completion
2018-01-01
Completion
2018-04-03

Countries

  • Lebanon

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03690622 on ClinicalTrials.gov